BANK VONTOBEL/CALL/PFIZER INC/29/0.1/20.09.24 | Delayed Deutsche Boerse AG 08:01:08 2024-07-04 EDT | ||
| 0.079 EUR | +12.86% |
|
| Current month | -13.58% | ||
| 1 month | -58.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 0.079 | +12.86% |
| 24-07-03 | 0.07 | -9.09% |
| 24-07-02 | 0.077 | -18.09% |
| 24-07-01 | 0.094 | +16.05% |
| 24-06-28 | 0.081 | +1.25% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 08:01 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| WKN | VM5CG5 |
| ISIN | DE000VM5CG50 |
| Date issued | 2023-11-13 |
| Strike | 29 $ |
| Maturity | 2024-09-20 (78 Days) |
| Parity | 10 : 1 |
| Emission price | 0.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.39 € |
|---|---|
| Lowest since issue | 0.058 € |
| Spread | 0.01 € |
| Spread % | 10.99% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7
USD
Average target price
31.92
USD
Spread / Average Target
+15.22%
- Stock Market
- Warrants
- Warrant
